Treating pain with open-label placebos: A qualitative study with post-surgical pain patients

Back Pain

Effects of open-label placebo on pain, functional disability and spine mobility in chronic back pain patients: a randomized controlled trial

Pain.

Kleine-Borgmann J, Schmidt K, Hellmann A, Bingel U

doi: 10.1097/j.pain.

COMMENTED

Acute Pain

Pain Response to Open Label Placebo in Induced Acute Pain in Healthy Adult Males

★ 3 Recommended and commented by Dr Roland Schreiber, Faculty Member

doi: 10.1097/ALN.0000000000003076.

Acute PainPain Management

ATHENA: A Phase 3, Open-Label Study Of The Safety And Effectiveness Of Oliceridine (TRV130), A G-Protein Selective Agonist At The µ-Opioid Receptor, In Patients With Moderate To Severe Acute Pain Requiring Parenteral Opioid Therapy

J Pain Res.

Bergese SD, Brzezinski M, Hammer GB, Beard TL, Pan PH, Mace SE, Berkowitz RD, Cochrane K, Wase L, Minkowitz HS, Habib AS

doi: 10.2147/JPR.S217563.

SPECIAL REPORT

HIV / AIDS

11. Konferenz der Internationalen AIDS-Gesellschaft (IAS) 2021

RECOMMENDED

Pain Relief

Deceptive and Nondeceptive Placebos to Reduce Pain: An Experimental Study in Healthy Individuals

★ 2 Recommended by Dr Roland Schreiber, Faculty Member

Clin J Pain.

Kube T, Rief W, Vivell MB, Schäfer NL, Vermillion T, Körfer K, Glombiewski JA

doi: 10.1097/AJP.0000000000000781.

COMMENTED

Back PainPain Management

Open-label placebo for chronic low back pain: A 5-year follow-up

★ 3 Recommended and commented by Dr Roland Schreiber, Faculty Member

Pain

Carvalho C, Pais M, Cunha L, Rebouta P, Kaptchuk TJ, Kirsch I

doi: 10.1097/j.pain.0000000000002162

Further Publications Pain

Impact of Galcanezumab on Total Pain Burden: A Post Hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study in Patients with Episodic Cluster Headache

J Pain Res

Andrews JS, Kudrow D, Rettiganti M, Oakes T, Bardos JN, Wenzel R, Kuruppu DK, Gaul C, Martinez JM

doi: 10.2147/JPR.S305066

SPECIAL REPORT

HIV / AIDS

11^e Conférence de la Société internationale sur le SIDA (IAS) 2021

Chronic Pain

Long-term use of naldemedine in the treatment of opioid-induced constipation in patients with chronic non-cancer pain: a randomized, double-blind, placebo-controlled phase 3 study